- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03870672
rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke (rTMS+CCFES)
February 22, 2024 updated by: Ela B. Plow, The Cleveland Clinic
Contralaterally Controlled FES Combined With Brain Stimulation for Severe Upper Limb Hemiplegia
This study is a necessary and important step in the development of a new therapy for upper limb functional recovery in patients with severe motor impairment.
It is the first clinical trial of non-invasive brain stimulation (repetitive transcranial magnetic stimulation or rTMS) delivered to excite the undamaged hemisphere (specifically the contralesional higher motor cortices or cHMC) in stroke.
Therefore, this study will determine whether the positive results obtained in our short-term pilot study can be made to last longer and produce functional benefits in severe patients with the application of brain stimulation in combination with long-term rehabilitation therapy.
Rehabilitation therapy administered is called contralaterally controlled functional electrical stimulation (CCFES).
Determining whether combining rTMS facilitating the cHMC with CCFES produces synergistic gains in functional abilities in severe patients is necessary for acceptance by the clinical community and to move this technology toward commercialization and widespread dissemination.
The proposed study will determine whether the combination of rTMS facilitating the cHMC with CCFES produces greater improvements in upper extremity function in severe participants who are ≥6 months from stroke onset than the combination of rTMS facilitating the damaged hemisphere (specifically the ipsilesional primary motor cortex, iM1) and CCFES or the combination of sham rTMS and CCFES.
The secondary purposes are to define which patients benefit most from the treatments, which may inform future device and treatment development and clinical translation, and to explore what distinct effects the three treatments have on the brain.
To accomplish these purposes, we are conducting a clinical trial that enrolls severe stroke patients.
Study Overview
Status
Recruiting
Detailed Description
Overall Study Design Summary: We propose a 5-yr RCT in which 72 stroke patients who are >6 months post-stroke are randomized to 12 wks of one of 3 treatments: (1) CCFES + cHMC facilitation, (2) CCFES + iM1 facilitation, (3) CCFES + Sham rTMS.
The treatment dose will be the same for all groups: 10 sessions per week (7.5 hrs) of self-administered CCFES-assisted hand opening exercises performed at home plus 2 sessions per week (2.5 hrs) consisting of group-specific rTMS and CCFES-mediated functional task practice performed in the laboratory.
Upper limb impairment, activity limitation, and patient-reported disability will be assessed at 0 (baseline), 6, 12 (end of treatment), 24, and 36 wks.
Neurophysiology (IHI and excitability of uncrossed output) will be assessed at 0 (baseline), 12 (end of treatment), and 36 wks, on a separate day from functional motor outcomes assessment.
MRI assessment of stroke lesion and location, and DTI assessment of corticospinal damage will be performed at baseline.
Study Type
Interventional
Enrollment (Estimated)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ela B. Plow, PhD PT
- Phone Number: 216-445-4589
- Email: plowe2@ccf.oeg
Study Contact Backup
- Name: Kyle J. O'Laughlin, MS
- Phone Number: 866-449-1394
- Email: olaughk@ccf.org
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Lerner Research Institute; Cleveland Clinic Foundation
-
Contact:
- Ela Plow, PhD
- Phone Number: 216-445-4589
- Email: plowe2@ccf.org
-
Principal Investigator:
- Ela Plow, PhD
-
Contact:
- Morgan Widina, MS
- Phone Number: 866-449-1394
- Email: widinam@ccf.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age 18 to 90 years old at time of randomization
- greater than 6 months since a first clinical cortical or subcortical, ischemic or hemorrhagic stroke
- severe upper limb hemiparesis defined as less than 10° active wrist extension or less than 10° active thumb abduction/extension or less than 10° active extension in at least two additional digits (i.e., will not meet minimum CIMT criteria)
- ability to follow 3-stage commands and can remember 2 items from a list of 3 items after 3 minutes
- adequate active movement of shoulder and elbow to position the paretic hand on one's lap for performance of functional task practice and CCFES-assisted hand opening exercises
- skin intact on hemiparetic arm
- surface electrical stimulation of the paretic finger and thumb extensors produces functional hand opening without pain
- able to hear and respond to cues from stimulator
- completed occupational therapy at least 2 months prior to enrollment (no concomitant OT)
- full volitional hand opening/closing of the non-paretic hand
- ability to follow instructions for putting on and operating the CCFES stimulator or a caregiver available to provide assistance
Exclusion Criteria:
- metal implant in the head
- history of seizures as an adult
- history of alcohol or substance abuse less than 10yrs prior to enrollment
- intake of anticonvulsants or anti-depressants contraindicated with TMS
- cardiac pacemaker or other programmable implant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: CCFES + rTMS facilitating cHMC
This rTMS paradigm is the "New Approach".
Facilitation of the intact hemisphere target (cHMC) will be achieved using 5Hz rTMS.
After rTMS, the participant will participate in one hour of CCFES-mediated functional task practice.
The therapist will instruct and guide the participants in practicing functional tasks with their paretic hand with the assistance of CCFES.
Tasks will involve using the paretic hand to pick up, manipulate, and release objects commonly used in daily life.
Early sessions will focus on simpler tasks, such as practicing opening the hand adequately to acquire an object.
|
Contralaterally Controlled Functional Electrical Stimulation (CCFES) uses electrical stimulation to open the weak hand.
Sticky patches called electrodes are placed on the participant's affected arm to stimulate the hand muscles, and a special glove is worn on the participant's strong hand and controls the stimulator.
When the participant opens the gloved hand, stimulation opens the weak hand; when they close the gloved hand, stimulation turns off and the weak hand relaxes.
During the clinic visits, participants will use CCFES to assist hand opening during functional training.
During participant home sessions, they will use CCFES to perform hand opening exercise.
Other Names:
Participants in this arm will receive rTMS-based facilitation of the contralesional dorsal premotor cortex (cPMd) located in the non-stroke hemisphere before start of each session.
High-frequency rTMS (5-Hz) will be delivered using 42 10-sec trains of 50 pulses each (total 2100 pulses) for a period of 24 minutes.
Immediately after the completion of rTMS, participants will undergo upper limb training + CCFES for a total of one hour.
Participants will receive these interventions 2 days a week for 12 weeks.
Other Names:
|
Active Comparator: CCFES + rTMS facilitating iM1
This rTMS paradigm is the "Conventional Approach".Facilitation of M1 will be achieved using 5Hz rTMS.
After rTMS, the participant will participate in one hour of CCFES-mediated functional task practice.
The therapist will instruct and guide the participants in practicing functional tasks with their paretic hand with the assistance of CCFES.
Tasks will involve using the paretic hand to pick up, manipulate, and release objects commonly used in daily life.
Early sessions will focus on simpler tasks, such as practicing opening the hand adequately to acquire an object.
|
Contralaterally Controlled Functional Electrical Stimulation (CCFES) uses electrical stimulation to open the weak hand.
Sticky patches called electrodes are placed on the participant's affected arm to stimulate the hand muscles, and a special glove is worn on the participant's strong hand and controls the stimulator.
When the participant opens the gloved hand, stimulation opens the weak hand; when they close the gloved hand, stimulation turns off and the weak hand relaxes.
During the clinic visits, participants will use CCFES to assist hand opening during functional training.
During participant home sessions, they will use CCFES to perform hand opening exercise.
Other Names:
Facilitation of M1 will be achieved using 5Hz rTMS.
High-frequency rTMS (5-Hz) will be delivered using 42 10-sec trains of 50 pulses each (total 2100 pulses) for a period of 24 minutes.
Immediately after the completion of rTMS, participants will undergo upper limb training + CCFES for a total of one hour.
Participants will receive these interventions 2 days a week for 12 weeks.
Other Names:
|
Sham Comparator: CCFES + Sham rTMS
This rTMS paradigm is the "Sham Approach".
Immediately after sham rTMS, the participant will participate in one hour of CCFES-mediated functional task practice.
The therapist will instruct and guide the participants in practicing functional tasks with their paretic hand with the assistance of CCFES.
Tasks will involve using the paretic hand to pick up, manipulate, and release objects commonly used in daily life.
Early sessions will focus on simpler tasks, such as practicing opening the hand adequately to acquire an object.
|
Contralaterally Controlled Functional Electrical Stimulation (CCFES) uses electrical stimulation to open the weak hand.
Sticky patches called electrodes are placed on the participant's affected arm to stimulate the hand muscles, and a special glove is worn on the participant's strong hand and controls the stimulator.
When the participant opens the gloved hand, stimulation opens the weak hand; when they close the gloved hand, stimulation turns off and the weak hand relaxes.
During the clinic visits, participants will use CCFES to assist hand opening during functional training.
During participant home sessions, they will use CCFES to perform hand opening exercise.
Other Names:
In the sham rTMS group, ipsilesional motor hotspot will be targeted in half the patients and cHMC location will be targeted in the other half (based on random assignment).
Immediately after the completion of rTMS, participants will undergo upper limb training + CCFES for a total of one hour.
Participants will receive these interventions 2 days a week for 12 weeks.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Upper Extremity Fugl-Meyer (UEFM)
Time Frame: Change in UEFM will be assessed at at 6 weeks, 12 weeks (end of treatment), 24 weeks, and 36 weeks.
|
The UEFM is a reliable and valid measure of post-stroke upper limb motor impairment.
The UEFM items take into account synergy patterns, isolated strength, coordination, and hypertonia.
Volitional movement of the upper limb (shoulder, elbow, forearm, wrist, and hand) is examined in and out of synergies.
Each item is graded on a 3-point ordinal scale (0, cannot perform; 1, perform partially; and 2, perform fully) and summed to provide a maximum score of 66.
The UEFM is classified as a body structure/function impairment measure on the ICF domain.
|
Change in UEFM will be assessed at at 6 weeks, 12 weeks (end of treatment), 24 weeks, and 36 weeks.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Neurophysiologic Assessments
Time Frame: Change in neurophysiologic indices will be measured at 12 weeks (end of treatment) and at 36 weeks, on a separate day from functional motor outcomes assessment.
|
Neurophysiologic assessments will be performed using TMS.
While patients are seated with forearms resting and supported on a flat surface, a 70mm figure-of-eight coil will be positioned over the scalp at locations corresponding to motor hotspots.
Coil placement and targeting will be guided using MRI-stereotaxy, same as with rTMS.
Surface EMG electrodes will be attached to paretic and non-paretic EDC (and other muscles, as explained below) to record MEPs and changes in ongoing muscle activity.
Inter-hemispheric interactions and excitability of pathways devoted to weak muscles will help characterize role of the intact, contralesional motor cortices.
|
Change in neurophysiologic indices will be measured at 12 weeks (end of treatment) and at 36 weeks, on a separate day from functional motor outcomes assessment.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Ela B Plow, PhD PT, Lerner Research Institute; Cleveland Clinic Foundation
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 14, 2019
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
April 30, 2025
Study Registration Dates
First Submitted
March 6, 2019
First Submitted That Met QC Criteria
March 8, 2019
First Posted (Actual)
March 12, 2019
Study Record Updates
Last Update Posted (Actual)
February 23, 2024
Last Update Submitted That Met QC Criteria
February 22, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-286
- R01HD098073 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Contralaterally Controlled Functional Electrical Stimulation
-
MetroHealth Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedCerebral PalsyUnited States
-
National Taiwan University HospitalRecruitingPeripheral Nerve InjuryTaiwan
-
VA Office of Research and DevelopmentCompletedStroke | Upper Extremity HemiplegiaUnited States
-
MetroHealth Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedStroke | Hemiparesis | FootdropUnited States
-
Prof. Dr. Antônio Marcos Vargas da SilvaCompleted
-
National Rehabilitation Center, Seoul, KoreaUnknown
-
University of Sao PauloSuspendedRehabilitation | Critical CareBrazil
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...Completed
-
University of FloridaCompletedHemiplegia | Cerebrovascular AccidentUnited States
-
University Health Network, TorontoCompletedSpinal Cord Diseases | Spinal Cord InjuriesCanada